March 2016

EMEA: PRESS RELEASE – For Immediate Release

The European ME Alliance (EMEA) has written to Queen Mary University London (QMUL) requesting that data from the PACE Trial is released for independent review.

The European ME Alliance is a collaboration of 15 ME organisations in 13 European countries who have the common aim of promoting biomedical research into Myalgic Encephalomyelitis (known as ME or ME/CFS) and increasing awareness of this debilitating neurological illness.

The refusal to release data goes against the current climate of openness and reflects poorly on any academic institution.

The failure to release this data also continues to do harm to patients across Europe where healthcare systems may base their policies on what is perceived by EMEA as quite flawed research.

The letter to QMUL is in the attachment above.

Further Information:

  1. Invest in ME Letter to MRC and Lancet



Last Update: 11 March 2016

Return to News

Membership into EMEA is open to all groups

Contact us if you are interested in influencing ME in Europe and beyond.